08:04:43 EDT Sat 13 Jun 2026
Enter Symbol
or Name
USA
CA



Q:STAA - STAAR SURGICAL CO - https://www.staar.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
STAA - Q0.128.16·29.058.628.37-0.53-1.8384.610,5905,71028.84  28.98  28.170135.87  15.58519:52:43May 2115 min RT 2¢

Recent Trades - Last 10 of 5710
Time ETExPriceChangeVolume
19:52:43Q29.000.1050
16:10:05Q28.37-0.531
16:10:05Q28.37-0.531
16:10:05Q28.37-0.531
16:10:04Q28.37-0.531
16:10:04Q28.37-0.531
16:04:29Q28.37-0.531
16:04:25Q28.37-0.531
16:04:06Q28.37-0.531
16:04:06Q28.37-0.531

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-05-21 16:01U:STAANews ReleaseSTAAR Surgical Announces Participation in Upcoming Investor Conferences
2026-05-13 16:01U:STAANews ReleaseSTAAR Surgical Reports First Quarter 2026 Results; Issues Shareholder Letter
2026-05-04 16:01U:STAANews ReleaseSTAAR Surgical to Host First Quarter 2026 Earnings Results Call and Webcast on May 13, 2026
2026-04-08 16:01U:STAANews ReleaseSTAAR Surgical Announces Preliminary Net Sales for First Quarter 2026
2026-03-03 16:02U:STAANews ReleaseSTAAR Surgical Issues Shareholder Letter
2026-03-03 16:01U:STAANews ReleaseSTAAR Surgical Reports Fourth Quarter and Fiscal Year 2025 Results
2026-02-25 16:01U:STAANews ReleaseSTAAR Surgical Surpasses 4 Million ICLs Sold Globally, Reflecting Ongoing Shift Away from Laser-Based Vision Correction
2026-02-23 16:01U:STAANews ReleaseSTAAR Surgical to Host Fourth Quarter and Fiscal Year 2025 Earnings Conference Call and Webcast on March 3, 2026
2026-02-17 16:01U:STAANews ReleaseFDA Expands U.S. Age Indication for EVO ICL as Long-Term Safety Data Reinforces Market Shift Away From Laser Vision Correction
2026-02-02 07:00U:STAANews ReleaseSTAAR Surgical Appoints Warren Foust and Deborah Andrews Interim Co-CEOs
2026-01-15 08:30U:STAANews ReleaseSTAAR Surgical and Broadwood Partners Enter Into Cooperation Agreement
2026-01-06 09:52U:STAANews ReleaseBroadwood Partners Comments on STAAR Surgical Shareholders' Rejection of the Company's Proposed Sale to Alcon
2026-01-06 08:47U:STAANews ReleaseSTAAR Surgical Announces Preliminary Results of Special Meeting of Stockholders
2025-12-19 12:59U:STAANews ReleaseBroadwood Partners Denounces STAAR Surgical's Fourth Delay of the Shareholder Vote on the Company's Proposed Sale to Alcon
2025-12-19 11:45U:STAANews ReleaseAlcon Exercises Right to Require STAAR Surgical to Adjourn its Special Meeting of Stockholders
2025-12-17 16:53U:STAANews ReleaseDefender Capital Reiterates Intention to Vote AGAINST STAAR Surgical's Proposed Sale to Alcon Inc.
2025-12-17 13:17U:STAANews ReleaseBroadwood Partners Issues Open Letter to STAAR Surgical Board Pledging Cooperation and Support When Vote on Alcon Transaction Fails
2025-12-17 10:55U:STAANews ReleaseSTAAR Stockholders Have a Choice: Vote FOR Alcon's Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder Value
2025-12-16 13:32U:STAANews ReleaseYunqi Capital Comments on Proxy Advisors' Updated Recommendations, Urges Shareholders to Continue to Back the Company's Standalone Trajectory
2025-12-16 09:12U:STAANews ReleaseIndependent Industry Analysts Recognize Value Provided to STAAR Stockholders by Amended Alcon Merger Agreement and Merits of Alcon Transaction